glp-1 mitochondria New research identifies a mechanism of action for the receptor, the target of GLP-1 diabetes drugs | Imperial News glp-1_ra_pharmacology [TUSOM | Pharmwiki]

A group of researchers led by Richard DiMarchi and Matthias Tschp has created an experimental drug that activates receptors of the GIP and glucagon hormones

Friedman School of Nutrition Science and Policy at Tufts University, recently served as lead chair and author of a clinical advisory titled Nutritional Priorities to Support GLP-1 Therapy for Obesity, published across four peer-reviewed journals and issued by four leading organizations in lifestyle medicine, obesity medicine, and nutritionthe American College of Lifestyle Medicine (ACLM), the American Society for Nutrition (ASN), the Obesity Medicine Association (OMA), and The Obesity Society (TOS)

When combined with GLP-1 agonism, glucagon receptor activation increases energy expenditure through thermogenesis, enhances fat oxidation and breakdown, improves metabolic rate in ways that counteract the metabolic slowdown typically accompanying weight loss, and may provide additional central appetite regulation

Industry compliance is non-negotiable